NCT02518971

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 176 (actual)
• Sponsor: University of Michigan · Academic / Other
• Sex: Male
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

The study aims to evaluate the efficacy of prophylactic tamsulosin in reducing the incidence of postoperative urinary retention in primary total knee and hip arthroplasty patients.

Detailed description

Prophylactic administration of tamsulosin will be compared to a placebo to evaluate the effectiveness in reducing the incidence of postoperative urinary retention in total hip and knee arthroplasty patients.

Conditions

• Postoperative Urinary Retention

Interventions

Type	Name	Description
DRUG	Tamsulosin	0.4 mg daily
DRUG	Placebo	one capsule daily

Timeline

• Start date: 2015-08-01
• Primary completion: 2018-06-05
• Completion: 2018-12-19
• First posted: 2015-08-10
• Last updated: 2019-04-12
• Results posted: 2019-04-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study